An anti-inflammatory and analgesic extract tablet of radix curcumae and its preparation process
By preparing chyluria-reducing extract tablets, the problems of unstable efficacy and high toxicity of existing drugs for treating filariasis and lymphedema and other lymphatic system diseases caused by various etiologies have been solved. This provides a highly efficient, safe, and economical treatment option, achieving effective protection of the lymphatic system and promoting lymphatic return.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Filing Date
- 2026-05-06
- Publication Date
- 2026-07-17
AI Technical Summary
Existing drug therapies for filariasis and lymphatic system diseases such as chyluria and lymphedema caused by various etiologies suffer from unstable efficacy, high toxicity, and low patient compliance, and there is a lack of safe and effective drug treatment options.
This invention provides a tablet containing chyle-clearing extract for reducing swelling. By transforming a traditional Chinese medicine formula into a modern preparation, it employs a high drug loading formula and a stable extraction process. Combined with TLC identification and HPLC content determination methods, quality control is ensured. Its anti-inflammatory, lymphatic endothelial protective, and lymphatic drainage mechanisms are verified through animal experiments and clinical studies.
It provides efficient, safe, and economical long-term treatment options for diseases such as chyluria and lymphedema. By establishing quality control standards and clear efficacy evaluation, it ensures the high efficiency and reproducibility of the treatment, and elucidates its mechanism of action at the cellular level, significantly reducing lymphedema and inflammation.
Smart Images
Figure CN122398891A_ABST